Hernández L, Pinyol M, Hernández S, Beà S, Pulford K, Rosenwald A, Lamant L, Falini B, Ott G, Mason D Y, Delsol G, Campo E
Laboratory of Pathology, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
Blood. 1999 Nov 1;94(9):3265-8.
Anaplastic large cell lymphoma (ALCL) is associated with the t(2;5)(p23;q35), which generates the NPM-ALK fusion gene encoding an 80-kD protein. Several studies have suggested that genes other than NPM may be fused to the ALK gene. Here we have identified TRK-fused gene (TFG) as a new ALK partner in 2 ALCL, 1 of which exhibited a t(2;3)(p23;q21). In these cases, TFG was involved in 2 different fusion genes, TFG-ALK(S) and TFG-ALK(L), coding respectively 85-kD and 97-kD chimeric proteins. The ALK breakpoint in these translocations was the same as in the classic t(2;5) translocation. These 2 proteins were both active in an in vitro tyrosine kinase assay showing that the new cloned cDNA sequences are translated into chimeric proteins with functional activity. These findings indicate that TFG can provide an alternative to NPM as a fusion partner responsible for activation of the ALK and the pathogenesis of ALCL.
间变性大细胞淋巴瘤(ALCL)与t(2;5)(p23;q35)相关,该易位产生编码80-kD蛋白的NPM-ALK融合基因。多项研究表明,除NPM外的其他基因可能与ALK基因融合。在此,我们在2例ALCL中鉴定出TRK融合基因(TFG)作为一种新的ALK伙伴基因,其中1例表现为t(2;3)(p23;q21)。在这些病例中,TFG参与了2种不同的融合基因,即TFG-ALK(S)和TFG-ALK(L),分别编码85-kD和97-kD的嵌合蛋白。这些易位中的ALK断点与经典的t(2;5)易位相同。这两种蛋白在体外酪氨酸激酶试验中均具有活性,表明新克隆的cDNA序列被翻译成具有功能活性的嵌合蛋白。这些发现表明,TFG可作为负责激活ALK和ALCL发病机制的融合伙伴替代NPM。